Your browser doesn't support javascript.
loading
CRISPR/Cas9­mediated hypoxia inducible factor­1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma.
Liu, Quan; Fan, Dahua; Adah, Dickson; Wu, Zhengzhi; Liu, Renyan; Yan, Qiao-Ting; Zhang, Yue; Du, Zhi-Yong; Wang, Dou; Li, Yan; Bao, Shi-Yun; Liu, Li-Ping.
Afiliação
  • Liu Q; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
  • Fan D; Department of Chinese and Western Integrative Medicine, The Eighth Affiliated Hospital of Sun Yat­Sen University, Shenzhen, Guangdong 518033, P.R. China.
  • Adah D; University of Chinese Academy of Sciences, Beijing 100049, P.R. China.
  • Wu Z; Department of Chinese and Western Integrative Medicine, The Eighth Affiliated Hospital of Sun Yat­Sen University, Shenzhen, Guangdong 518033, P.R. China.
  • Liu R; Department of Pharmacology, Upstate Medical University, State University of New York, Syracuse, NY 13210, USA.
  • Yan QT; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
  • Zhang Y; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
  • Du ZY; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
  • Wang D; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
  • Li Y; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
  • Bao SY; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
  • Liu LP; Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong 518020, P.R. China.
Oncol Rep ; 40(5): 2547-2557, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30226584

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Subunidade alfa do Fator 1 Induzível por Hipóxia / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncol Rep Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quimioembolização Terapêutica / Carcinoma Hepatocelular / Subunidade alfa do Fator 1 Induzível por Hipóxia / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncol Rep Ano de publicação: 2018 Tipo de documento: Article